Edition:
United States

Tandem Diabetes Care Inc (TNDM.OQ)

TNDM.OQ on NASDAQ Stock Exchange Global Market

12.83USD
18 May 2018
Change (% chg)

$1.14 (+9.75%)
Prev Close
$11.69
Open
$11.69
Day's High
$12.94
Day's Low
$11.59
Volume
558,972
Avg. Vol
344,527
52-wk High
$12.94
52-wk Low
$2.14

Chart for

About

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System... (more)

Overall

Beta: -0.12
Market Cap(Mil.): $522.54
Shares Outstanding(Mil.): 44.70
Dividend: --
Yield (%): --

Financials

  TNDM.OQ Industry Sector
P/E (TTM): -- 39.22 32.53
EPS (TTM): -16.04 -- --
ROI: -144.76 14.34 12.63
ROE: -2,676.03 17.22 14.50

BRIEF-Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump

* TANDEM DIABETES CARE-ANNOUNCED RECEIPT OF CE MARK APPROVAL FOR T:SLIM X2 INSULIN PUMP WITH DEXCOM G5® MOBILE CONTINUOUS GLUCOSE MONITORING INTEGRATION

Apr 30 2018

BRIEF-Tandem Diabetes Care Files For Mixed Shelf Of Up To $100 Mln

* TANDEM DIABETES CARE INC FILES FOR MIXED SHELF OF UP TO $100 MILLION - SEC FILING Source : https://bit.ly/2JtPqwk Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 26 2018

BRIEF-Tandem Diabetes Care Reports Qtrly Net Loss Per Share, Basic And Diluted Of $1.82

* TANDEM DIABETES CARE REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

Apr 26 2018

BRIEF-Tandem Diabetes Care Announces Insulin Pump Products Distribution Agreements In Australia And New Zealand

* TANDEM DIABETES CARE SAYS ANNOUNCES AGREEMENTS FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN AUSTRALIA AND NEW ZEALAND Source text for Eikon: Further company coverage:

Apr 23 2018

BRIEF-Tandem Diabetes Care Q1 Sales $27 Mln Vs I/B/E/S View $25 Mln

* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY FIRST QUARTER 2018 RESULTS

Apr 10 2018

BRIEF-Tandem Diabetes Care And Movi SpA Announce Agreement For Distribution Of Insulin Pump Products In Italy

* TANDEM DIABETES CARE AND MOVI SPA ANNOUNCE AGREEMENT FOR DISTRIBUTION OF INSULIN PUMP PRODUCTS IN ITALY

Apr 09 2018

BRIEF-Tandem Diabetes Care Q4 Sales $40.3 Million

* ‍SALES FOR Q1 OF 2018 ARE ESTIMATED TO BE 18 PERCENT - 19 PERCENT OF ANNUAL SALES​

Mar 01 2018

BRIEF-Tandem Diabetes Care Applies For Health Canada Medical Device License

* TANDEM DIABETES CARE APPLIES FOR HEALTH CANADA MEDICAL DEVICE LICENSE

Feb 20 2018

BRIEF-Tandem Diabetes Care Files For Offering Of 13.5 Mln Shares Of Co's Common Stock

* TANDEM DIABETES CARE FILES FOR OFFERING OF 13.5 MILLION SHARES OF CO'S COMMON STOCK, PAR VALUE $0.001 PER SHARE - SEC FILING‍​‍​ Source text: (http://bit.ly/2nmA5Fh) Further company coverage:

Jan 29 2018

BRIEF-Tandem Diabetes Care Sees Q4 2017 GAAP Sales Of About $39 Mln to $40 Mln

* TANDEM DIABETES CARE ANNOUNCES PRELIMINARY 2017 RESULTS AND PROVIDES 2018 GUIDANCE

Jan 09 2018

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $124.24 +0.39
Roche Holding Ltd. (ROG.S) CHF224.55 +0.55
Roche Holding Ltd. (RO.S) CHF229.20 +1.00
Insulet Corporation (PODD.OQ) $87.52 -0.03

Earnings vs. Estimates